In the BioHarmony Drug Report Database
Nateglinide
Starlix (nateglinide) is a small molecule pharmaceutical. Nateglinide was first approved as Starlix on 2000-12-22. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus.
Trade Name
|
Starlix |
|---|---|
Common Name
|
nateglinide |
ChEMBL ID
|
CHEMBL783 |
Indication
|
type 2 diabetes mellitus |
Drug Class
|
Antidiabetic, SGLT2 inhibitors, not phlorozin derivatives |
Image (chem structure or protein)